Form 4: Progyny Director Lloyd H. Dean Acquires Shares and Options

Director Lloyd H. Dean acquired shares and options in Progyny, Inc. on May 23, 2024, according to a Form 4 filing with the SEC.

Summary

• On May 23, 2024, Lloyd H. Dean, a director of Progyny, Inc., acquired 5,147 shares of common stock and 23,212 stock options.
• The shares were acquired at a price of $0.
• The stock options have an exercise price of $27.15 and will vest on May 23, 2025, with an expiration date of May 22, 2034.
• The 5,147 shares of common stock were acquired as restricted stock units (RSUs) that will vest on May 23, 2025, subject to continued service.
• Following the transaction, Dean directly owns 11,701 shares of Progyny, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction by a company director, which can be interpreted as a sign of confidence, but it's not a major event.

Positives

• A director's acquisition of shares and options can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The RSUs and stock options are subject to vesting conditions based on continued service, suggesting an incentive for the director to remain with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the beneficial ownership of Progyny's securities by one of its directors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it reflects insider confidence.

Key Dates